Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems

MARLBOROUGH, Mass., April 20, 2016 /PRNewswire/ -- Boston Scientific (NYSE: BSX) has received CE Mark approval for the new EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional labeling for all previously implanted EMBLEM S-ICD Systems. 

Verseon presents further trial data on the low bleeding risk of its family of preclinical anti-coagulant drugs at BioEurope conference

Fremont, California – Further evidence on the low bleeding profile of Verseon’s novel family of anti-coagulants was presented at the BioEurope conference in Stockholm, Sweden last week. The new data reinforces the promise of Verseon’s novel, highly selective direct thrombin inhibitors (DTIs) as a potential treatment for venous thrombotic disorders while maintaining a lower bleeding risk than current drugs.

Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology

ST. LOUIS, April 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a long-term follow-up study on the efficacy of the Stereotaxis Niobe® ES magnetic navigation system reported by Lund University Hospital in Sweden, which validate improved long-term clinical outcomes compared to manual navigation for ablation treatment of atrial fibrillation (AF).

Medtronic CoreValve® System Maintains Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients at Three Years

DUBLIN and CHICAGO - April 3, 2016 - Medtronic plc (NYSE: MDT) today announced new data from the High Risk Study of the CoreValve U.S. Pivotal Trial that show superior clinical outcomes for transcatheter aortic valve replacement (TAVR) with the CoreValve® System compared to surgical aortic valve replacement (SAVR) out to three years. The positive data were published in the Journal of American College of Cardiology and simultaneously presented during a Featured Clinical Research session at 65th Annual Scientific Session & Expo of the American College of Cardiology (ACC.16).

Thumbnail

ACC.16: PET/CT study links stress to heightened risk of cardiovascular disease

Researchers have used PET/CT imaging to link stress-related amygdala activation in the brain with arterial inflammation and an increased risk of eventual cardiovascular disease events, according to results of a study presented today at ACC.16 in Chicago.

Emory first in Georgia to offer new image-guided treatment for PAD

ATLANTA – Emory Johns Creek Hospital is the first in Georgia, and among the first in the United States, to offer a unique device to treat peripheral arterial disease (PAD), a condition caused by the narrowing or blockage of the peripheral arteries – most commonly in the legs.

UW Medicine's Regional Heart Center Taps HealthLevel for Data Analytics

MOUNTAIN VIEW, Calif., March 30, 2016 /PRNewswire/ -- The UW Medicine Regional Heart Center has implemented a new approach for continuous quality improvement in the cardiac catheterization laboratory using Foundations™ from HealthLevel. Critical information that traditionally is difficult to obtain and use, is now available instantly, enabling leadership, doctors and staff to make timely evidence-based decisions.

Thumbnail

AHRQ releases comparative effectiveness review of noninvasive testing for coronary artery disease

A systematic comparative effectiveness review of noninvasive testing for coronary artery disease found there was no significant difference in MI or all-cause mortality between testing strategies across settings and pretest risk groups. The Agency for Healthcare Research and Quality (AHRQ) conducted the review and released the report on March 29.

Displaying 1609 - 1616 of 2645

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.